The potential of technology to significanlty improvethe healthcare ecosystem is enormous.Within the pharmaceutical industry, technology powers all aspects of drug development – from discovery to development, manufacturing and how we connect with our customers. It enables us to develop new medicines better, faster and at lower costs.
At Lilly, our purpose is to unite caring with discovery to create medicines that make life better for people around the world.We believe technologywill play an even bigger role in the future to deliver on this purpose. To underscore the value Lilly is placing on technology, since I became CIO in 2016, the scope of the role has expanded. Notably, by elevating the position to the Executive Committee and extending the responsibilities to include digital health, advanced analytics and data sciences and information security – this underscores the power we believe data, analytics and technology togethercan unleash to descrese cycle times and cost of drug development, increase probalility of technical success and provide enhanced customer experience and satistiation. This is a trend we are seeing across many industries as IT elevates its role as a strategic business partner.
Digital health is Key to the Future of Healthcare
We are in a new era in healthcare where patients, providers and payors expect more information, support, and value for medicines than ever before. For example, people are already using technology to manage or improve their health, such as tracking steps or monitoring heart rate using wearables and apps.